Işıl Güney, Ph.D.
          Ulysses Advisory Group LLP


This email address is being protected from spambots. You need JavaScript enabled to view it. 

          Tel: +90 (532) 502 72 43

Dr. Güney is a co-founder of Ulysses Advisory Group and has been working with life science startups to assist develop and bring promising technologies to the global market.. She was trained as a molecular biologist and holds a B.S. degree from Xavier University of Louisiana, and a Ph.D. from Brown University, where she studied the molecular mechanisms of cancer and cellular aging.

Dr. Güney worked previously as a postdoctoral fellow at the Dana-Farber Cancer Institute, Harvard Medical School, implementing cutting edge molecular tools for the identification of novel therapeutic targets for the treatment of advanced prostate cancer. Her investigations were supported by the United States Military’s Department of Defense.  For her work, Dr. Guney was presented with the Young Investigator Award by the Prostate Cancer Foundation.  She identified numerous molecules that may be used in hormone refractory prostate cancer treatment and prostate cancer detection, and her findings have been patented.

Most recently, Dr. Güney worked as the Director of R&D at Bio Istanbul, a public-private partnership established to develop an integrated biomedical research park and innovation cluster under the auspices of the Ministry of Environment and Urbanization of the Republic of Turkey.

Dr. Güney is a founding member and Board Director of MIT Enterprise Forum Turkey, dedicated to strengthening regional technology clusters, supporting entrepreneurship and promoting the growth of an innovation economy in Turkey, and served as a mentor to entrepreneurs at the Health Technologies Incubation Center of Inovita, a collaborative life sciences platform established by Bosphorus University, Sabancı University and Istanbul University.

Dr. Güney is fluent in Turkish, English and Spanish with basic conversational skills in French. She currently lives in Istanbul.